Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05112211

Multi-model Image of Doxycycline in TAO

A Multi-model Image to Evaluate the Efficacy of Doxycycline in Thyroid Associated Ophthalmopathy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the efficacy of doxycycline treating Thyroid Associated Ophthalmopathy by multi-modal image.

Detailed description

Thyroid Associated Ophthalmopathy is one of autoimmune orbital diseases characterized by enlargement of the extraocular muscles and increase in fatty or/and orbit connective tissue volume affecting the appearance and visual function of the eyes. Different degrees of exophthalmos, eyelid aperture, lid retraction and lid lag are common symptoms apprearing in TAO. The improvement of exophthalmos is usually measured with Hertel instrument and the change of eyelid is measured with millimeter ruler. All these measurements are subjective, low reliable and less accurate. TAO can be classified into active phase and inactive phase according to the activity score and wait-and-see or surgery are widely chosen for patients in inactive phase. But still a progression and reoccurrence can be a big challenge for ophthalmologists. This is a perspective cohort study to evaluate the efficacy of doxycycline in TAO by multi-model image.

Conditions

Interventions

TypeNameDescription
DRUGDoxycycline Hyclatepatients administrated with doxycycline tablets 100mg orally per day

Timeline

Start date
2022-01-01
Primary completion
2025-12-01
Completion
2026-12-01
First posted
2021-11-08
Last updated
2023-11-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05112211. Inclusion in this directory is not an endorsement.

Multi-model Image of Doxycycline in TAO (NCT05112211) · Clinical Trials Directory